TransCode Advances TTX-MC138 in Phase 1a Cancer Trial
Boston, Massachusetts, U.S., September 28, 2026 TransCode Therapeutics has reported updated clinical findings from its ongoing follow-up of the...
bioelectronic medicine
Advertisement
Lakewood-Amedex Reports Positive Nu-3 Antimicrobial Data
Sarasota, Florida, U.S., September 28, 2026 Lakewood-Amedex Biotherapeutics has announced positive Minimum Inhibitory Concentration (MIC) data demonstrating in vitro...
SetPoint Medical Expands RA Neuroimmune Therapy Access
Atlantic City, New Jersey, U.S., September 28, 2026 SetPoint Medical has announced an important clinical-access milestone following the completion...
SetPoint Medical Expands RA Neuroimmune Therapy in Oregon
Valencia, California, USA, September 16, 2026 SetPoint Medical announced that Oregon Health & Science University (OHSU) has become the...
SetPoint Medical Delivers First FDA-Approved RA Device in N.C.
VALENCIA, Calif., June 29, 2026 SetPoint Medical has announced a significant milestone in the expansion of its FDA-approved SetPoint...
Advertisements
Zymeworks Launches $125M Share Repurchase Program
VANCOUVER, British Columbia, May 14, 2026 Zymeworks Inc. announced that its Board of Directors has approved a new 2026...
SetPoint System Could Cut Lifetime RA Care Costs by $350,000
VALENCIA, Calif., May 14, 2026 SetPoint Medical announced the publication of a peer-reviewed health economics study demonstrating that its...
SetPoint Medical Starts MS Study for Neuroimmune Therapy
VALENCIA, California, April 30, 2026 SetPoint Medical announced the first patients enrolled in a pilot clinical study evaluating its...
Autonomix RF Neurolysis Study Selected as Top Abstract
THE WOODLANDS, Texas, March 4, 2026 Autonomix Medical, Inc. announced that its novel transvascular peripheral radiofrequency (RF) nerve neurolysis...
Advertisement
